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Abstract: Over the past 20 years brain Single Photon Emission Computed Tomography (SPECT) imaging has developed 
a substantial, evidence-based foundation and is now recommended by professional societies for numerous indications 
relevant to psychiatric practice. Unfortunately, SPECT in clinical practice is utilized by only a handful of clinicians. This 
article presents a rationale for a more widespread use of SPECT in clinical practice for complex cases, and includes seven 
clinical applications where it may help optimize patient care. 
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INTRODUCTION 
  “SPECT techniques provide a powerful window into the 
function of the brain and promise to become an important 
component of the routine clinical evaluation of patients with 
neurological and psychiatric diseases”[1]. 
  This opening sentence to Holman and Devous’ 1992 arti-
cle “Functional Brain SPECT: The Emergence of a Powerful 
Clinical Method,” highlighted the hope held for functional 
neuroimaging nearly two decades ago. A consistently grow-
ing body of research supports SPECT’s clinical utility. Four-
teen years ago, Vasile wrote in the Harvard Review of Psy-
chiatry [2], “The clinical utility of SPECT in neuropsychiatry 
is well established.” Nearly a decade ago, Camargo [3] 
wrote, “Brain SPECT … is rapidly becoming a clinical tool 
in many places. The importance of this technique should not 
be overlooked, particularly in cerebrovascular diseases, 
dementias, epilepsy, head injury, obsessive-compulsive dis-
order, Gilles de la Tourette's syndrome, schizophrenia, de-
pression, panic disorder, and drug abuse.” Despite its evi-
dence-base for multiple areas relevant to diagnosis and 
treatment few psychiatrists have adopted SPECT or other 
functional neuroimaging techniques in clinical practice.  
  This article lays out the evidence-based argument for the 
addition of SPECT for patients with complex presentations 
or who are treatment resistant. The article focuses on SPECT 
for three reasons. First, SPECT cameras are available in 
every major North American, European and Asian hospital 
making it the most widely available imaging modality avail-
able today. Second, SPECT has extensive research validating 
its usefulness for problems often faced by psychiatrists and  
is endorsed by scientific review bodies for many indications 
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relevant to psychiatry. And, third, SPECT is among the least 
expensive neuroimaging tools and has had insurance reim-
bursement codes for greater than 20 years. 
  SPECT’s prolific use in peer-reviewed research supports 
that it is a well-established and reliable measure of brain 
function (regional cerebral blood flow—rCBF) [4]. Both the 
American College of Radiology [5] and the European Soci-
ety of Nuclear Medicine (ESNM) [6] have published similar 
evidence-based guidelines for using SPECT to enhance pa-
tient care. Commonly accepted clinical indications for 
SPECT include: 
  Evaluating patients for cerebrovascular disease. 
  Evaluating patients with suspected dementia including 
early detection, differential diagnosis, and in the pre-
dementia phase.  
  Presurgical localization of epileptic foci. 
  Evaluation of traumatic brain injury, especially in the 
absence of computed tomography (CT) and/or magnetic 
resonance imaging (MRI) findings.  
  Evaluation of suspected inflammation to provide helpful 
information in progressive inflammatory disorders in-
cluding viral encephalitis, vasculitis, and HIV-
encephalopathy. 
  Assessing brain death. 
  It is obvious to practicing psychiatrists that all of these 
indications, except perhaps brain death and the pre-surgical 
location of epileptic foci, are potentially valuable in clinical 
practice. Psychiatrists commonly evaluate and treat dementia 
and the consequences of brain trauma, cerebral vascular dis-
ease, inflammation and infections. Besides these common 
indications, the ESNM guidelines also state, “SPECT can be 
useful in other indications such as movement disorders and 
psychiatric diseases (e.g. for follow-up of depression).”  Brain SPECT Imaging in Complex Psychiatric Cases  The Open Neuroimaging Journal, 2011, Volume 5    41 
SPECT BASICS 
  SPECT uses radioisotopes bound to neurospecific phar-
maceuticals to evaluate rCBF and indirectly metabolic activ-
ity. Hexamethylpropyleneamine oximine (HMPAO) and 
ethylcysteinate dimer ( ECD) are two commonly available 
FDA-approved radiopharmaceuticals; both provide regional 
cerebral blood flow (rCBF) images where the patient acts as 
his own control. A normal SPECT scan shows full, even, 
symmetrical perfusion [7], with the most intense perfusion in 
the cerebellum with HMPAO [8] and in the occipital lobes 
with ECD [9]. In reading SPECT images, experienced clini-
cians look for symmetry and areas of increased and de-
creased perfusion. See Figs. (1) and (2) for examples of 
healthy HMPAO scans. When evaluating SPECT, it is im-
portant to know the age of the patient. rCBF changes signifi-
cantly over time. Children tend to have very active brains, 
older people less so [10].  
SPECT HAS A SERIOUS IMAGE PROBLEM 
  SPECT has a serious ‘image’ problem related to many 
clinicians’ misunderstanding of its advantages and disadvan-
tages. Five areas contribute to this problem: 
1.  There is a widely held idea that the clinical use of SPECT 
is restricted by limited resolution. Early SPECT practice 
utilized single-headed cameras that produced lower reso-
lution images of about 12mm. However, sophisticated 
multi-headed gamma detectors with fan beam collimators 
have been available for the past two decades and can 
produce images with a resolution of 6mm. George re-
ported that multi-head SPECT camera resolution is simi-
lar to PET at considerably less cost [11]. Multi-headed 
SPECT cameras cost between $100,000 for refurbished 
systems to $400,000 for new systems while PET/CT 
cameras cost between $1.5 to 3 million dollars [12]. This 
cost is then reflected in the price of the scans, with a 
SPECT scan averaging $1,100 versus a PET scan starting 
at $3,800.    
2.  Many nuclear medicine departments provide minuscule 
gray scale horizontal, coronal, and sagittal SPECT slices. 
The poor quality images are hard to read and understand. 
When clinicians cannot easily understand the images, 
they dismiss the technology as useless. Several current 
manufacturers provide software for three-dimensional 
image renderings that allow for more easily understand-
able images, such as those used in this article. Even 
though it is always necessary to evaluate the sliced im-
ages for appropriate detail, clinicians and patients need 
images that they can understand. 
3.  Functional neuroimaging training seldom combines radi-
ologists and psychiatrists. Since psychiatry has yet to 
embrace this technology, many radiologists and nuclear 
medicine physicians have little to no training or experi-
ence in utilizing SPECT for neuropsychiatric indications. 
Even though the SPECT literature is replete with studies 
showing areas of increased perfusion in a number of psy-
chiatric diagnoses and epilepsy most radiologists or nu-
clear physicians report only areas of decreased perfusion. 
More education and collaboration is needed among spe-
cialties.  
4.  Another common SPECT criticism is radiation exposure, 
especially in children. However, the average radiation 
exposure for one SPECT scan is 0.7rem (i.e., similar to a 
nuclear bone scan or head CT) and is considered safe. 
The Health Physics Society states, "There is no direct 
evidence of radiation ever causing any harm at the expo-
sure levels encountered with diagnostic radiological ex-
aminations "[13]. The benefit-risk ratio of such radiation 
exposure needs to be evaluated against the considerable 
costs (monetary, and in terms of suffering and dysfunc-
tion) imposed by treatment resistant psychiatric disor-
ders.  
5.  A final concern is why use SPECT over other brain im-
aging procedures that do not require ionizing radiation, 
namely perfusion/arterial spin labeling MRI and quantita-
tive electroencephalography (QEEG). Perfusion/arterial 
spin labeling MRI is advantageous in that it doesn’t use 
ionizing radiation (it uses magnetically labeled endoge-
nous blood water) and is minimally invasive; however, it 
is limited based on its low-signal-to-noise ratio and low 
temporal resolution. An alternative brain imaging modal-
ity, QEEG, does not require radiation and is low in cost 
($600), however, it is limited to measuring brain wave 
activity at the scalp, and gives limited information re-
garding subcortical structures.  
CLINICAL APPLICATIONS OF BRAIN SPECT   
IMAGING 
Several important patterns have emerged from SPECT re-
search that has direct application to day-to-day clinical prac-
tice. Here are 7 examples: 
 
Healthy Surface Rendering. 
Fig. (1). Shows a healthy 3D surface rendering of SPECT informa-
tion, looking at the top 45% of brain perfusion, anything below that 
level shows up as a hole or a dent. The holes do not mean no perfu-
sion, they mean low perfusion, compared to a healthy dataset. Ac-
tivity below the top forty-fifth percentile is 3 standard deviations 
below normal [10]. A healthy scan shows full, even, symmetrical 
perfusion.  42    The Open Neuroimaging Journal, 2011, Volume 5  Amen et al. 
1. Overall Decreased Perfusion 
  This pattern is often associated with toxicity, illness or 
insult to the brain. It is frequently seen in drug and alcohol 
abuse, abuse of prescription medications such as benzodi-
azepines, environmental toxins, such as carbon monoxide 
poisoning, infectious disease, such as meningitis, anoxic 
states, significant hypothyroidism, anemia, chemotherapy 
and severe dehydration. Seeing this pattern does not give the 
etiology, but alerts clinicians to search for causes which will 
allow them to understand it.  
  Here is an example: A couple came for evaluation after 
their marital therapist told them she thought they should get 
divorced. They’d been treated for three years and spent 
nearly $20,000 in care. The husband’s diagnosis was mixed 
personality disorder with narcissistic and antisocial features. 
The couple’s family physician recommended another opin-
ion that included SPECT scans. The husband’s scan showed 
overall decreased perfusion (Fig. 3). The husband reported 
that he didn’t drink alcohol and had never used drugs, which 
his wife confirmed. The scan results caused his physician to 
think through a completely different differential diagnosis 
beyond personality disorder. It turned out that the husband 
worked in a furniture factory, finishing cabinets. The inha-
lants found in finishing products may compromise brain 
functioning and show a toxic pattern on scans [14]. Marital 
therapy is destined to fail until the husband is removed from 
the toxic environment. This information significantly 
changed the treatment plan and was instrumental in helping 
the couple’s marriage. 
2. Traumatic Brain Injury (TBI) Patterns 
  TBI is a major public health concern. TBI survivors 
commonly face a range of psychiatric disorders, affecting 
functional status, cognition, and mood [15]. Of course, not 
everyone with a significant brain injury has lasting symp-
toms. Those who do, however, present daunting problems of 
differential diagnosis. But how does a psychiatrist know 
about individual patients and brain injury unless they look? 
Relying on clinical history alone is inadequate. Even upon 
extensive questioning, many patients forget that they have 
sustained a significant brain injury. The following case dem-
onstrates this frustrating problem: 
 
Fig. (3). Toxic Surface Scan notice the “Swiss cheese, shriveled 
appearance, indicating areas of decreased perfusion. 
 
  A 26 year old male patient with severe impulsivity and 
depression in a drug treatment program was asked 10 times, 
with extensive examples, whether or not he had a brain in-
jury. He said no each time. His SPECT scan (Fig. 4), how-
ever, showed evidence of substantial hypoperfusion, consis-
tent with trauma in the left frontal-temporal lobe region. 
When asked again, he then remembered a motorcycle acci-
dent where he broke his left jaw, near the site of his SPECT 
deficit. 
 
Fig. (4). Trauma. Asymmetrical decreased perfusion left frontal 
temporal lobe. 
 
Healthy Active Rendering. 
Fig. (2) Shows a healthy 3D active rendering of SPECT informa-
tion, looking at areas of increased perfusion. Blue equals average 
perfusion, red equals the top 15% of perfusion and white is the top 
8%. Activity above these levels is 2 and 3 standard deviations 
above normal outside the cerebellum(10). A healthy active scan 
with HMPAO shows increased perfusion in the cerebellum. Brain SPECT Imaging in Complex Psychiatric Cases  The Open Neuroimaging Journal, 2011, Volume 5    43 
  SPECT can help identify if trauma is present and which 
brain system or systems are affected. Common findings in 
trauma on SPECT include: 
  focal decreased near sight of injury and/or opposite side 
(contra coup) 
  asymmetrical hypoperfusion in the prefrontal, temporal, 
parietal or occipital lobes 
  flattening of the prefrontal pole 
  decreased anterior temporal poles 
  decreased contralateral cerebellar perfusion. 
  SPECT aids in understanding TBI patients’ symptoma-
tology and assists clinicians in developing targeted treatment 
strategies [16, 17]. For example, decreased prefrontal cortex 
perfusion is often associated with executive dysfunction and 
may be helped with psychostimulants or other strategies to 
enhance frontal lobe function; whereas decreased temporal 
lobe perfusion is often associated with irritability and mood 
instability and may be helped with anticonvulsant medica-
tion. Literature indicates that SPECT helps evaluate perfu-
sion abnormalities not only in blunt brain trauma, but also in 
cases of post-concussive syndrome and whiplash [18]. Brain 
injured patients with normal EEG, CT, and/or MRI scans 
often complain of headaches, memory loss, concentration 
difficulties, dizziness, perceptual sensitivities, and emotional 
lability. Such patients may be labeled as malingering, when 
there are significant and demonstrable functional abnormali-
ties present. Researchers investigating the differences be-
tween functional and structural imaging techniques have 
found SPECT to be more sensitive for patients with varying 
degrees of head trauma [19].  
  Researchers have also compared the differences between 
functional and structural imaging in relation to clinical out-
come and prognosis. Jacobs et al. [16] used SPECT to pro-
spectively evaluate 67 mild-to-moderate brain injured pa-
tients. Each patient had a clinical evaluation and SPECT 
scan within four weeks of the initial injury and three months 
after the first scan. Of the 33 patients who showed no sig-
nificant abnormalities on their initial scan, 97% resolved 
their clinical symptoms within three months. By contrast, in 
the 34 patients with abnormal initial SPECT scans, 59% con-
tinued to experience significant clinical symptoms three 
months later. The positive predictive value of an abnormal 
initial scan was only 20/34 (59%), but if the second scan 12 
months later was also abnormal the sensitivity for the repeat 
SPECT was 19/20 (95%). These authors suggest that nega-
tive initial SPECT studies are a reliable predictor of a favor-
able clinical outcome.  
  SPECT assists in the diagnosis, prognosis, and treatment 
of TBI patients. SPECT may also help uncover brain trauma 
in clinically confusing or complex cases because  patients 
often fail to report or forget about significant brain injuries, 
perhaps due to peri-traumatic amnesia. A limitation for 
SPECT’s use in brain trauma is that typically no prior 
SPECT study is available for comparison. Therefore, it is 
often not possible to date the trauma with neuroimaging. 
Remote trauma from childhood often presents neuroimaging 
findings similar to those seen in more recent trauma.  
3. Evaluating Cognitive Decline 
  To date, autopsy reports have been the “gold standard for 
an Alzheimer’s Disease (AD) diagnosis.” However, research 
suggests that SPECT, when used in conjunction with clinical 
history and other diagnostic tests, is helpful when evaluating 
patients who are experiencing cognitive decline [20] and 
should be used to help differentiate AD, vascular dementia 
(VaD), frontal lobe dementia (FLD), suspected Lewy Body 
Dementia (LBD), normal pressure hydrocephalus (NPH) and 
pseudodementia (PSD) if the diagnosis is in doubt [21]. The 
functional brain imaging patterns associated with AD in-
clude decreases in the posterior cingulate gyrus, parietal and 
medial temporal lobes; FLD include frontal and temporal 
lobe deficits; VaD, a vascular pattern of decreased activity in 
multiple areas; LBD often shows decreased occipital lobe 
perfusion; NPH is associated with enlarged ventricles out of 
proportion to cortical atrophy; and PSD often shows an ab-
sence of dementia patterns with increased limbic activity 
[22]. This differential is critical because the use of high po-
tency antipsychotics in patients with LBD, which often af-
fects the occipital lobes on SPECT [23], can cause severe 
and sometimes irreversible deterioration. Patients diagnosed 
with different dementia disorders often present with similar 
symptomatology (e.g., social withdrawal and behavioral dis-
inhibition). Because treatments for these disorders vary, dif-
ferential diagnosis is critical, particularly since some demen-
tia patients will have a reversible cause, such as depression 
or normal pressure hydrocephalus, or a cause they may be 
significantly stabilized with aggressive intervention, such as 
VaD. 
  Here is a case example: L, a 73 year old male, suffered 
with persistent memory problems. His neurologist, without 
the benefit of imaging, diagnosed him with AD. Memantine 
and donezepil had no effect. Two years later, his family 
brought him for further evaluation. His SPECT scan showed 
significantly enlarged ventricles, without concomitant corti-
cal atrophy (Fig. 5). His scan did not show the typical low 
posterior cingulate and bilateral temporal-parietal hypoperfu-
sion, consistent with AD. Given the pattern, and subsequent 
MRI, he was diagnosed with normal pressure hydrocephalus 
(NPH). After a shunt his memory markedly improved.  
 
Fig. (5). Transaxial Slices. Slices 12 and 13 show inverted lobster 
pattern associated with ventricular enlargement. 44    The Open Neuroimaging Journal, 2011, Volume 5  Amen et al. 
  Some would argue that an MRI would be a more appro-
priate study in evaluating NPH, which the authors agree. 
Yet, functional imaging studies like SPECT provide a wealth 
of other data, such as giving information on areas of in-
creased and decreased perfusion, in addition to enlarged ven-
tricles, making it is useful screening tool. For example, 
Bonte et al. [24] performed SPECT studies in patients with 
possible dementia and compared them to images of an eld-
erly healthy control group. Histopathologic correlation was 
available in 54 patients (with autopsy in 51, with biopsy in 
three). The results of the study showed SPECT diagnoses 
were true-positive in 37, true-negative in eight, false-positive 
in three, and false-negative in six patients. Sensitivity was 
86%; specificity, 73% and the positive predictive value was 
92%, with an accuracy of 83%. The authors concluded that 
SPECT assists in the early and late diagnoses of AD and in 
the differential-diagnosis of the dementias when there is a 
complicated or confusing clinical picture.  
4. Negative Emotionality and Hyperfrontality 
  Hyperfrontality, or increased perfusion in the prefrontal 
cortex and anterior cingulate gyrus, is associated with a 
number of different psychiatric illnesses that have a common 
theme of cognitive inflexibility or getting stuck on negative 
thoughts or negative behaviors, such as in obsessive compul-
sive disorder (OCD) [25, 26], autism, posttraumatic stress 
disorder, and certain types of anxiety and mood disorders 
[27, 28]. This pattern is often seen in patients who struggle 
with being rigid, inflexible and oppositional [29], and 
crosses several different diagnostic groups.  
  When SPECT scans detect the hyperfrontality pattern, it 
opens new avenues for intervention since this finding has 
been associated with predicting a positive treatment response 
to serotonergic medication in depression [30-34] and OCD 
[35, 36], predicting a positive response to sleep deprivation 
[37, 38] and repetitive transcranial magnetic stimulation[39] 
for depression, predicting treatment response to a cingu-
lotomy in OCD [40], and help in distinguishing OCD from 
ADHD [41].  
  Hyperfrontality will never give a classic DSM diagnosis 
per se, but rather it provides new directions for treatment by 
providing a picture of the brain physiology underlying the 
clinical presentation.    
  Here is a clinical example. V, a 17 year old male, had 
severe temporal lobe epilepsy. He also had aggression that 
was non-responsive to behavioral interventions. His SPECT 
scan showed severely decreased perfusion in his left tempo-
ral lobe (Fig. 6) consistent with epilepsy, and he showed 
severely increased perfusion in the anterior cingulate gyrus 
and lateral frontal lobes (Fig. 7), a pattern consistent with 
OCD. Even though V did not have clear OCD symptoms, he 
was rigid, inflexible and easily upset when something did not 
go his way. With the addition of sertraline, an antidepressant 
that tends to lower rCBF in this brain region [31], his behav-
ior significantly improved. Managing V without the benefit 
of scans handicapped the doctor, patient and family. 
5. Behavioral Problems and Hypofrontality 
  Hypofrontality, decreased perfusion or activity in the 
prefrontal cortex, is another important SPECT finding that is 
often helpful in understanding and targeting treatment in 
individual patients. Hypofrontality is associated with a nega-
tive response to serotonergic medication in depression [30] 
and clozapine in schizophrenia [42] as well as with predict-
ing relapse in alcoholics [43], improved response to acetyl-
choline-esterase inhibitors for memory and behavior in AD  
[44, 45], predicting a poor response to ketamine in fibromy-
algia patients [46] and improved response to stimulants in 
patients with ADHD symptoms during a concentration chal-
lenge [47]. Hypofrontality is also associated with antisocial 
symptoms, impulsive behaviors, and murder [48, 49] as well 
as with completed suicide, which is often an impulsive act 
[50]. When hypofrontality is present in depressed patients, it 
is important to be vigilant in their care, as well as involve 
family support, as they may be less likely to respond to typi-
cal antidepressant medications and they may not have the 
cognitive resources to follow through with recommenda-
tions. 
  Given its broad range of involvement in different types of 
psychiatric illness hypofrontality, like other findings, will 
not give a specific psychiatric diagnosis, but it allows the 
clinician to know the underlying pathophysiology of the pa-
tient’s presenting problem and can help explain issues with 
cognitive impairment or behavioral problems. 
6. Mood Instability, Memory Problems and Temporal 
Lobe Abnormalities 
  Evaluating temporal lobe function is important in psychi-
atric medicine, especially as it relates to the evaluation of 
patients with memory problems, mood instability, aggres-
sion, and receptive and expressive language [51]. As de-
scribed above, the temporal lobes are commonly affected in 
brain injury. Their function however cannot be evaluated 
simply by clinical phenomenology. SPECT offers a reliable 
tool to evaluate temporal lobe function. According to De-
vous et al. ”Both SPECT and PET have localizing power 
 
Fig. (6). Outside Surface Scan severe left temporal lobe hypoperfu-
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approaching that of combined scalp and depth EEG.”[52] 
Patients with epilepsy have high psychiatric comorbidity 
[53], and psychiatrists increasingly rely on the use of anti-
convulsants as ‘mood stabilizers,’ which are shown to stabi-
lize or calm overall brain activity and perfusion, especially in 
the temporal lobes [54, 55]. 
  Temporal lobe epilepsy (TLE) is one of the most fre-
quently encountered chronic epileptic disorders and is asso-
ciated with numerous psychiatric symptoms, such as de-
pressed mood, anergia, irritability, euphoric mood, atypical 
pain, insomnia, fear, and anxiety [56]. The medial temporal 
lobes are frequently involved in TLE and they are difficult to 
evaluate with routine EEG studies and therefore may be 
missed. SPECT findings in epilepsy most often reveal focal 
decreased perfusion in the interictal phase and focal in-
creased perfusion in the seizure’s ictal phase. SPECT adds to 
the clinical evaluation of temporal lobe function by identify-
ing area(s) of abnormality and showing deficits not seen by 
EEG. 
  Based on the authors’ clinical experience, when abnor-
malities in the temporal lobes are seen (either low or high 
perfusion) and mood instability or temper problems are pre-
sent, anticonvulsants provide a rational treatment option 
[57]. If there are memory or learning issues (and low tempo-
ral lobe perfusion), acetylcholine-esterase inhibitors may be 
helpful [58], always taking into consideration the clinical 
picture.  
  Here is an example: C, age 12, was hospitalized for at-
tacking another child at school. This was his third psychiatric 
hospitalization. C had been diagnosed with ADHD at age 6, 
but stimulants caused him to hallucinate. At age 9 he was 
hospitalized for an aggressive episode, diagnosed with a 
mood disorder and placed on an antidepressant without bene-
fit. By age 12 he had been in psychotherapy for 3 years, also 
without benefit. Given his resistant illness, and the tens of 
thousands of dollars spent on his care, a brain SPECT study 
was ordered which showed severe left temporal lobe hypop-
erfusion (Fig. 8). Unilateral temporal lobe hypoperfusion is 
often seen with epileptic phenomena [52]. On an anticonvul-
sant C’s behavior normalized and he has maintained his pro-
gress for over 10 years. 
 
Fig. (8). C’s Brain SPECT Study severe hypoperfusion left tempo-
ral lobe (arrow). 
7. Subtyping Dimensional Behavior to Predict Treatment 
Response 
  SPECT’s use in clinical practice dovetails closely with 
the spirit of NIMH’s RDoC initiative which looks to develop 
new ways of classifying psychopathology based on observ-
able behavior and neurobiological measures [59]. In order to 
construct such a system, it is necessary to obtain accurate 
measures of the functioning of the brain systems which sup-
port various normal and abnormal emotions, undergird criti-
cal functions such as attention and memory, and modulate 
functions such as aggression. SPECT scans have the possi-
bility of facilitating the subtyping of mental illnesses, such as 
depression, ADHD, obsessive-compulsive disorder, and ag-
gression based on brain system pathophysiology.  
SUBTYPING AGGRESSION 
  The role of brain function in aggression is one of 
NIMH’s five major domains of interest and an area where 
SPECT imaging may provide immediate clinical help. From 
the authors’ work with 75 murderers, and hundreds of pa-
tients who have exhibited serious aggressive behavior rang-
ing from assault, robbery, rape, kidnapping, arson, bomb-
ings, to road rage, and stalking, we have seen that aggressive 
behavior is not defined by one single brain finding, but 
rather clusters in at least three different patterns. The first is 
impulsive aggression, associated with hypofrontality, a find-
ing reported in antisocial personality disorder [60, 61]. Pa-
tients with a compromised prefrontal cortex are frequently 
unable to regulate aggressive impulses and are at higher risk 
for exhibiting violent activity than other patients. The second 
cluster we have labeled ‘compulsive aggression,’ often asso-
ciated with hyperfrontality, where people act out because 
they cannot get negative thoughts out of their minds, or be-
cause they are extremely rigid and inflexible. The third clus-
 
Fig. (7). Active scan severe hyperfrontality (arrow). 46    The Open Neuroimaging Journal, 2011, Volume 5  Amen et al. 
ter of aggressive patients we’ve seen have SPECT findings 
of temporal lobe abnormalities. Soderstrom et al. [62] 
retrospectively evaluated violent subjects’ SPECT and MRI 
scans and compared them to the SPECT results obtained 
from a group of volunteers who had no history of a neuro-
logical or psychiatric disorder, head trauma, or metabolic 
disease. Sixteen of the 21 impulsively violent subjects 
showed some hypoperfusion in the temporal and/or frontal 
lobes upon visual inspection. By contrast, MRI failed to 
show any corresponding structural damage or abnormalities 
in this sample of violent offenders. Another study of recidi-
vistic violent offenders [63] revealed that the largest func-
tional deficits in their violent patients were found in the tem-
poral lobe. These abnormalities were similarly found in 
subjects whose structural CT scans were normal. Knowing a 
violent patient’s underlying brain pattern may be helpful to 
getting them the right help. In the authors’ experience we 
have often seen multiple patterns associated with violence, 
such as low prefrontal cortex and temporal lobe perfusion.  
  Here are two examples of 15 year old males, multiple 
murderers, who had significantly different SPECT patterns, 
which would lead to different clinical management deci-
sions. 
  KK was diagnosed with ADHD, dyslexia and depression. 
He had been evaluated by two psychiatrists and placed on a 
psychostimulant and SSRI without benefit. He was arrested 
after bringing weapons to his high school. After he was re-
leased from jail he murdered his mother and father and then 
went back to his high school the next morning and shot 24 
people, killing two more. As part of his pre-trial evaluation, 
a SPECT scan was performed and showed severe overall 
decreased perfusion, especially in the area of the left medial 
temporal lobe and inferior orbital prefrontal cortex. The scan 
was consistent with prior toxic exposure, anoxia or infection. 
The SPECT scan and history raise the possibility that an 
anticonvulsant (given the severe decreased left temporal lobe 
perfusion) followed by a psychostimulant (to enhance his 
low prefrontal cortex perfusion) was worth considering to 
help modulate his aggressive impulses. 
  PP had been diagnosed with ADHD and dyslexia. In a 
rage he murdered his mother and eight year old sister. PP’s 
SPECT scan showed significant hyperfrontality, especially 
in the anterior cingulate gyrus. As noted above, this presen-
tation is more likely to respond to an SSRI.  
  Here is the same symptom presentation, multiple murder, 
but very different brain patterns. The differences in the scan 
patterns give suggestions for different treatment regimens.  
SUBTYPING DEPRESSION 
  Anxiety and depressive disorders are two of the most 
common psychiatric problems worldwide and subtyping 
these disorders using brain system pathology is an important 
step in improving treatment outcomes [64]. Functional imag-
ing, including SPECT, helps to elucidate this process in in-
dividual patients. As noted above, hyperfrontality is associ-
ated with a positive response to SSRIs in depressed and anx-
ious patients, while hypofrontality is associated with a nega-
tive response, and has been reported in completed suicides. 
Little et al., on the other hand, found that lower prefrontal 
activity prior to treatment was associated with a positive 
response to buproprion and venlafaxine [65]. These medica-
tions involve enhancing dopamine and norepinephrine, 
which in the authors’experience, tend to enhance prefrontal 
cortex activity, while SSRIs tend to be calming [31]. Up to 
50 or 60% of patients with chronic epilepsy have various 
mood disorders including depression and anxiety [66, 67]. 
Using SPECT gives the clinician a more rational reason to 
use anticonvulsants when focal areas of increased or de-
creased perfusion are seen, especially in the temporal re-
gions. Likewise, if overall decreased perfusion is present, it 
alerts the clinician to look for toxic or metabolic causes of 
the problem, or if a brain trauma pattern is seen, commonly 
associated with anxiety and mood disorders, this can be in-
vestigated further as well.  
CONCLUSION 
  There are a number of important areas where SPECT has 
the potential to provide relevant information to help person-
alize treatment to patients’ specific brain system pathophysi-
ology rather than rely solely on general diagnostic and/or 
therapeutic categories. In this paper we described 7 such 
areas. Furthermore, in the authors’ experience, another im-
mediate benefit of using brain SPECT imaging is that the 
patient’s and family’s guilt, shame and stigma are signifi-
cantly reduced as they see their illness as medical rather than 
moral with concurrent improvements in treatment compli-
ance. In the authors’ opinion, brain SPECT or any other neu-
roimaging modality should always occur in conjunction with 
clinical assessment since it is not the isolated diagnostic
 ac-
curacy that has greatest importance but rather the value 
added to
 routine clinical assessment. 
  Over the last quarter century, there has been much dis-
cussion of the “Future of Psychiatry” [68] as we move into a 
more biologically based paradigm. How would we maintain 
our subjective patient focus within this new framework? 
Reynolds, Lewis, Detre, Schatzberg and Kupfer [69] have 
weighed in on this work in progress. One thing that is be-
coming very clear is that our resident trainees may require 
more exposure to translational neuroscience during their 
early years of residency and neuroimaging needs to be an 
important component of this curriculum. A recent report 
demonstrated the integration of a neuroimaging module 
within a residency program had wide approval by residents. 
Other programs have experimented with variations but 
within the neurology rotation of the PGY-1 year. The Psy-
chiatry RRC of the ACGME will need to take this on in ear-
nest for the development of the field. 
  This is an exciting time in the history of psychiatry, as 
the field will likely significantly change over the next 30 
years to incorporate functional neuroimaging in clinical prac-
tice. Functional magnetic resonance imaging (fMRI) among 
other techniques are often seen as proving the future of neu-
roimaging. Yet these techniques are much more expensive 
and are more technically difficult to administer. The authors’ 
hope is that SPECT does not get left out because of a lack of 
understanding or training in the use of this valuable tool.  
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